Phagenesis® in focused on the innovation for the treatment of dysphagia.
Phagenesis® mission is to transform the lives of people with dysphagia, using revolutionary treatments developed through a commitment to scientific and clinical excellence.
The first product in the portfolio is Phagenyx®, a treatment for the cause of dysphagia which restores the neurological control of swallowing.
The Phagenyx® system is the result of more than 20 years of research and development led by Professor Shaheen Hamdy.
If you want to know more about Phagenesis® please get in touch.